Literature DB >> 16986040

Prostate cancer: epidemiology and screening.

M K Brawer, E D Crawford, J Fowler, M S Lucia, F H Schröeder.   

Abstract

The challenge continues-to find better methods of screening for prostate cancer, of determining who should undergo needle biopsy, and of predicting who will fail initial therapy. Investigators are looking at the value of neural networks and an array of markers to provide improved screening and prognostic information.

Entities:  

Year:  2000        PMID： 16986040      PMCID： PMC1557464     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


  40 in total

1.  The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985).

Authors:  M Roach; J Krall; J W Keller; C A Perez; W T Sause; R L Doggett; M Rotman; H Russ; M V Pilepich; S O Asbell
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

2.  Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications.

Authors:  M S Cookson; N E Fleshner; S M Soloway; W R Fair
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

Review 3.  Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.

Authors:  M A Rubin; M Buyyounouski; E Bagiella; S Sharir; A Neugut; M Benson; A de la Taille; A E Katz; C A Olsson; R D Ennis
Journal:  Urology       Date:  1999-03       Impact factor: 2.649

4.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.

Authors:  A W Partin; M W Kattan; E N Subong; P C Walsh; K J Wojno; J E Oesterling; P T Scardino; J D Pearson
Journal:  JAMA       Date:  1997-05-14       Impact factor: 56.272

5.  Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.

Authors:  M T Gettman; A Pacelli; J Slezak; E J Bergstralh; M Blute; H Zincke; D G Bostwick
Journal:  Urology       Date:  1999-09       Impact factor: 2.649

6.  Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng./ml.

Authors:  J E Fowler; J Sanders; S A Bigler; J Rigdon; N K Kilambi; S A Land
Journal:  J Urol       Date:  2000-05       Impact factor: 7.450

7.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

Authors:  A W Partin; J Yoo; H B Carter; J D Pearson; D W Chan; J I Epstein; P C Walsh
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

8.  Prostate specific antigen levels after radical prostatectomy in patients with organ confined and locally extensive prostate cancer.

Authors:  A Stein; J B deKernion; R B Smith; F Dorey; H Patel
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration.

Authors:  G J Miller; J M Cygan
Journal:  J Urol       Date:  1994-11       Impact factor: 7.450

10.  Incidence and prognostic significance of lymphatic and vascular invasion in radical prostatectomy specimens.

Authors:  R R Bahnson; S M Dresner; W Gooding; M J Becich
Journal:  Prostate       Date:  1989       Impact factor: 4.104
View more
  4 in total

Review 1.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

2.  Potential clinical importance of the activation peptide of prostate-specific antigen.

Authors:  Laura M Voeghtly; Ida B Thøgersen; Zuzana Valnickova; Kristian W Sanggaard; Charleen T Chu; Tim D Oury; Jan J Enghild
Journal:  Int J Clin Exp Pathol       Date:  2009-06-20

3.  Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.

Authors:  Renan A Pereira; Roberto S Costa; Valdair F Muglia; Fábio Franca Silva; Joyce S Lajes; Rodolfo B Dos Reis; Gyl Eb Silva
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

4.  Cyclin D1 expression in prostate carcinoma.

Authors:  R A Pereira; R C Ravinal; R S Costa; M S Lima; S Tucci; V F Muglia; R B dos Reis; G E B Silva
Journal:  Braz J Med Biol Res       Date:  2014-05-02       Impact factor: 2.590
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.